Pharmaceutical industry publications

Pharma 2020: Supplying the future - Which path will you take?

In this report, we discuss the main trends dictating the need for a new approach to the manufacturing and distribution of medicines, together with some of the techniques and technologies that will help the industry make the necessary changes.

Cause for cautious optimism: Life sciences venture capital investment rebounds, but deal volume declines

Companies in the Life Sciences sector, which includes the biotechnology and medical device industries, recovered in terms of dollar investments during the first quarter of 2011.

Medical Technology Innovation Scorecard: The race for global leadership

The report is a multifaceted assessment of the capacity of countries to adapt to the changing nature of innovation. While there has been much anecdotal evidence involving the shift of innovation away from the US to new locals around the world, PwC analyzed and quantified the specific factors that contribute to medical technology innovation.

Biotech reinvented: Where do you go from here?

Governments around the world are trying to cut healthcare costs, and finding new drugs is getting harder. We've taken a closer look at what this means for the biotech industry in particular.

Global pharma looks to India: Prospects for growth

India has now a growing and increasingly sophisticated pharmaceutical industry of its own. It is likely to become a competitor of global pharma in some key areas, and a potential partner in others.

Pharma 2020: Challenging business models – Which path will you take?

The fourth in the series, this report explores how a pharmaceutical company's fully integrated business model may not be the best option for the industry in 2020 and why more creative collaboration models may be more attractive.